Prof. Peirong Ding 丁培荣
Chief Physician, Professor
Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Individualized sphincter-preserving surgery for low rectal cancer, hereditary colorectal cancer treatment and prevention, laparoscopic colorectal surgery, and multidisciplinary care for liver metastases.
Dr. Ding is Director of the Colorectal Department at Sun Yat-sen University Cancer Center. Dr. Ding graduated from Sun Yat-sen University in 2002 and earned a doctoral degree in 2010. In 2009–2010, Dr. Ding was a visiting scholar at Memorial Sloan-Kettering Cancer Center. Clinical focus includes comprehensive treatment of colorectal cancer and gastrointestinal stromal tumors, screening, and genetic counseling.
Professional roles
- Member, Guangdong Branch of Chinese Medical Association
- Vice Chair, Youth Committee of MDT Professional Committee, Surgical Branch of Chinese Medical Doctor Association
- Member, Youth Expert Committee, Chinese Society of Clinical Oncology (CSCO)
- Member, Genetics Group, Colorectal Cancer Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Ding Peirong). Papers usually list the name as Peirong Ding or Ding P.
Selected publications
152 papers on PubMed matched by name and affiliation; 39 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Lett, 2026 (senior author): POSTN(+) cancer-associated fibroblasts forming fortress-like barrier to mediate immunotherapy resistance in colorectal cancer. PubMed 42309220
- BMC Cancer, 2026 (senior author): Impact of mucinous histology on the efficacy of neoadjuvant immunotherapy in localized mismatch repair-deficient colorectal cancer. PubMed 42204495
- J Clin Oncol, 2026 (senior author): Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial. PubMed 41712876
- Int J Surg, 2026 (senior author): Proposal of a novel model for identifying complete response and nonoperative management in dMMR colon cancer following neoadjuvant immunotherapy: a retrospective cohort study. PubMed 41085679
- Dis Colon Rectum, 2025 (senior author): Surgical Outcomes in Metastatic Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer After Disease Control With Immune Checkpoint Inhibitors: A Retrospective Observational Study. PubMed 40576174
- NPJ Precis Oncol, 2025 (senior author): Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study. PubMed 40652024
- Eur J Surg Oncol, 2025 (senior author): Efficacy and safety of subtotal pelvic peritonectomy for colorectal cancer patients with peritoneal metastasis confined to the pelvic cavity. PubMed 40022888
- Transl Gastroenterol Hepatol, 2025 (senior author): Trends in epidemiology, clinicopathological characteristics and survival outcomes among patients with synchronous early-onset colorectal liver metastases in the United States from 2010 to 2019. PubMed 40337759
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion